摘要
针对将中医的证和证候用于中药新药临床疗效评价指标,文章从辨证规范的经验决策对证候疗效评价的影响、权威文献辨证标准对证候疗效评价的影响和病证所属症状的虚拟性对证候评价的影响3个方面质疑评价结果的客观性和科学性。认为把证和证候作为中药新药临床疗效评价指标的根本问题是辨证规范问题,后者现存诸多原则性问题,导致证和证候用于疗效评价成为一个伪命题。
In the paper, the author proposed 3 points to query the evaluation results of new Chinese drugs based on TCM syndrome types or TCM symptoms and signs. The author thought that the evaluation of curative effect based on TCM syndrome could be influenced by clinical experience, authority documents, and the virtuality of symptoms. Conclusively, why was the evaluation of curative effect based on TCM syndrome not objective and scientific should be that the problem of syndrome standardization.
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2015年第11期3815-3817,共3页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
国家"十二五"重大新药创制项目"中药新药临床评价研究技术平台"(No.2012ZX09303-017)
国家临床重点专科建设项目经费资助
国家中医药管理局临床中药学重点学科
辽宁中医药大学杏林学者青蓝工程~~
关键词
证
证候
疗效评价指标
客观性
科学性
辨证规范
TCM syndrome
TCM symptoms and signs
Index of therapeutic evaluation
Objectivity
Scientificity
Syndrome differentiation standardization
